1. Home
  2. CPNG vs RPRX Comparison

CPNG vs RPRX Comparison

Compare CPNG & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coupang Inc.

CPNG

Coupang Inc.

HOLD

Current Price

$16.78

Market Cap

32.3B

ML Signal

HOLD

RPRX

Royalty Pharma plc

HOLD

Current Price

$57.48

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPNG
RPRX
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3B
25.9B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CPNG
RPRX
Price
$16.78
$57.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$32.00
$51.40
AVG Volume (30 Days)
18.3M
2.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
1.90%
EPS Growth
37.50
N/A
EPS
N/A
0.67
Revenue
$34,534,000,000.00
$2,378,193,000.00
Revenue This Year
$13.15
$38.63
Revenue Next Year
$13.75
$4.73
P/E Ratio
N/A
$85.33
Revenue Growth
14.09
5.06
52 Week Low
$14.92
$34.63
52 Week High
$34.08
$60.44

Technical Indicators

Market Signals
Indicator
CPNG
RPRX
Relative Strength Index (RSI) 48.61 52.10
Support Level $14.98 $54.95
Resistance Level $16.91 $58.84
Average True Range (ATR) 0.56 1.30
MACD 0.03 -0.21
Stochastic Oscillator 65.21 37.99

Price Performance

Historical Comparison
CPNG
RPRX

About CPNG Coupang Inc.

Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: